Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Climb Bio ( (CLYM)) has issued an ...
New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody CLYM116 Phase 1 trial initiation expected in Q4 2025, with ...
BOSTON - Vor Bio (NASDAQ:VOR), whose stock has surged over 137% in the past year and 20% in the last week alone, announced Monday that clinical data from a Phase 3 study of telitacicept in adults with ...
Hosted on MSN
Climb Bio announces CLYM116 preclinical data
Climb Bio (CLYM) announced results from a completed nonhuman primate study comparing CLYM116 to sibeprenlimab, a first-generation anti-APRIL monoclonal antibody. The company is hosting a virtual ...
[BEIJING] Chinese e-commerce company Alibaba said on Wednesday (Sep 24) it plans to open its first data centres in Brazil, France and Netherlands as it accelerates its global strategy for artificial ...
The Chinese Ecommerce company, Alibaba, announced on Wednesday, September 23, 2025 that it has planned to open its First of many AI data centres in major countries including Brazil, France, and ...
Among 107 evaluable patients, the overall response rate (ORR) was 96.3%, including a complete or stringent complete response (CR/sCR) in 83.2%. In CAR-T-naïve patients, ORR and CR/sCR rates were 98.9% ...
Bar what it described as a “placebo wobble,” Moonlake Therapeutics AG turned in positive results from the phase III trials of sonelokimab in treating hidradenitis suppurativa (HS), only to see its ...
Biopharma financings from January through September 2025 totaled $47.1 billion, a sharp decline from 2024’s $86.7 billion during the same period and well below the highs of 2020 and 2021. The slowdown ...
Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Erika Rasure is globally-recognized as a leading ...
Drew Harwell is a technology reporter for The Washington Post. His work was honored by the Gerald Loeb Awards in 2024 and the George Polk Awards in 2021. He joined The Post in 2014. You can contact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback